Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DON | Ann: Ceasing to be a substantial holder - J.P. Mo | 03/07/13 | 0 | 1.0K | |||
|
|||||||
DON | Ann: Change in substantial holding - J.P. Morgan | 03/07/13 | 0 | 1.0K | |||
|
|||||||
DON | Ann: Annual Report to shareholders 2011 | 27/06/13 | 0 | 1.0K | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 961 | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 939 | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 918 | |||
|
|||||||
DON | Ann: Half Yearly Report and Accounts | 13/05/13 | 0 | 664 | |||
|
|||||||
DON | Ann: Quarterly Activities Report | 15:28 | 0 | 814 | |||
|
See All Discussions